Navigation Links
Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Company's Anthrax Therapeutic
Date:9/25/2007

with or without an antibiotic."

Anthim(TM) Background

Anthim is high affinity monoclonal antibody that targets the protective antigen component of anthrax infection, blocking the bacteria's ability to form deadly toxins. It is being developed for prophylaxis and post-exposure treatment of inhalation anthrax. Anthim has been granted Fast Track status and Orphan Drug Designation by the FDA and is being developed under the FDA Animal Rule, a regulatory process specifically designed for the development of medical countermeasures to bioterror threats. In April of 2007, Anthim was selected to R&D Directions' list of "100 Great Investigational Drugs.

About Elusys' Heteropolymer Antibody(TM) Technology

HP Antibodies represent a new approach for the treatment of antibiotic resistant infections distinct from traditional therapies. HP Antibodies utilize natural immune system mechanisms to clear pathogens and provide a means to develop novel drug candidates targeted against bacterial, viral and fungal infections. By targeting a unique immune receptor, HP Antibodies enhance a natural clearance mechanism and direct the rapid removal of pathogens from the circulation to tissue macrophages. Elusys is currently working on novel approaches to the treatment of Staphylococcus and Candida infections using HP antibodies.

About Elusys

Elusys is a privately held biopharmaceutical company focused on the development of antibody-based therapeutics for the treatment of life- threatening infectious disease. Current venture investors include Essex Woodlands Health Ventures LLC, Invesco Private Capital, Crescendo Ventures, MedImmune Ventures and Pfizer. For more information please visit http://www.elusys.com.


'/>"/>
SOURCE Elusys Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pelosi: Bush Veto of Stem Cell Bill Says No to the Hopes of Million of Families Across America
2. Trichomoniasis: Most Common Curable STD in U.S. Affects 7.4 Million Annually
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
5. Phase III Clinical Trial with 4-Month Long-Acting Formulation of Triptorelin: Ipsen Decides Not to Perform Further Administration
6. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
7. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
8. Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical Trial Data
9. MIV Therapeutics Announces Pivotal Test Results Further Validating Company Stent Coatings Meet Critical FDA Fatigue Guidelines
10. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
11. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... DIEGO and WALTHAM, Mass., July 29, 2015 ... is investigating whether certain officers and ... their fiduciary duties to shareholders.  AMAG Pharmaceuticals operates ... maternal health, anemia, and cancer supportive care.  The ... reduce the risk of preterm birth in women ...
(Date:7/29/2015)... Heska Corporation (NASDAQ: HSKA - News; ... diagnostic and other specialty veterinary products , today reported financial ... Second Quarter 2015 Highlights with Prior Year Comparison: ... $1.829 million, from $917 thousand. , Blood Analyzer and ... , Core Companion Animal revenue was up 19% to ...
(Date:7/29/2015)... 2015 The Judicial Panel on Multidistrict Litigation ... to centralize Inferior vena cava (IVC) Filter lawsuits filed ... Medical, have already been centralized by the JPML. ... at risk for a pulmonary embolism. The filters are ... lungs. Claims against Bard and Cook involve incidents of ...
Breaking Medicine Technology:Robbins Arroyo LLP Is Investigating the Officers and Directors of AMAG Pharmaceuticals, Inc. (AMAG) on Behalf of Shareholders 2Heska Reports Financial Results for the Second Quarter of 2015 2Heska Reports Financial Results for the Second Quarter of 2015 3Heska Reports Financial Results for the Second Quarter of 2015 4Heska Reports Financial Results for the Second Quarter of 2015 5Heska Reports Financial Results for the Second Quarter of 2015 6Heska Reports Financial Results for the Second Quarter of 2015 7Heska Reports Financial Results for the Second Quarter of 2015 8IVC filter litigation continues; law firm provides free information to IVC filter patients 2
(Date:7/29/2015)... , ... July 29, 2015 , ... Avatar Solutions has ... Systems (CAHPS) for PQRS Survey. , The CAHPS for PQRS Survey collects ... of 100 or more eligible providers must participate or they will receive a 2% ...
(Date:7/29/2015)... ... July 29, 2015 , ... In an ... with the problems of substance abuse that face today’s society, A Forever Recovery ... come to their rehabilitation center. The facility, located in Southwest Michigan hosted a ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Conventional theories ... and trade goods and services may be able to unlock mysteries about the behavior ... Graduate University , Boston University, and Columbia University. , The findings, published July 29 ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... production, announced today that Columbia University Medical Center, located in New York, NY, ... studio makes it easy for physicians and scientists to immediately access worldwide TV ...
(Date:7/29/2015)... ... July 29, 2015 , ... Abt ... within Abt’s U.S. Health division. In her position, Ramkeesoon will help build ... to joining Abt, Ramkeesoon spent close to a decade at ICF International, most ...
Breaking Medicine News(10 mins):Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 2Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 3Health News:MADD Victim Services Specialist Visits A Forever Recovery Rehabilitation Facility 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 3Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 2Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 3Health News:Selena Ramkeesoon Joins Abt Associates as Vice President for Strategic Communications 2
... largest meat processor, Maple Leaf Foods, on Tuesday decided to ... of its meat // products with an unknown contaminant. ... when Maple Leaf Employees found syringe casings at the company's ... Federal agency and CFIA's food safety officer, Garfield Balsom took ...
... World Ayurveda Congress at the University of Pune on ... Anbumani Ramadoss, //announced a series of steps to be ... India and abroad. He said, 'In a scenario where ... India’s rich tradition needed to be tapped and packaged ...
... wonder then, that the University of Queensland, Queensland ... David Fleay's Wildlife Park and the Zoological Society ... interesting project. The combined project is an artificial ... Monday and scientists believe the technique can be ...
... filed an appeal with the Pakistan Cricket Board (PCB) to ... tribunal on Nov 1.// ,Shoaib handed over the ... newspaper Wednesday quoted the PCB spokesperson as saying. ,Another ... ban by the same doping tribunal, filed his appeal to ...
... study that by actually allowing a stream of mild electrical ... stimulate a person’s mind helping him definitely to clearly recall ... ordinarily be able to do. ,Neuroscientist Lisa Marshall of ... found that applying electrical stimuli to the brain scalp which ...
... hearted - there is a 1 in 300 chance of dying ... England Sir Liam Donaldson has said in a cautionary message . ... WHO's campaign on the need for hospitals to address hygiene issues ... the chances of dying in an aircrash hollow , where the ...
Cached Medicine News:Health News:Government Announces Steps To Promote Ayurvedic Medicine 2
Anti-Tg and Anti-TPO are two major autoantibodies implicated in autoimmune related thyroiditis and aid in the differential diagnosis of Hashimoto's thyroiditis and Graves' disease....
... is an automated, turbidimetric, whole- blood assay ... the ability of activated platelets to bind ... of the VerifyNow IIb/IIIa assay device contains ... this analysis. Within the well is an ...
... The Company's first commercial product is ... with single-use, disposable assay devices . The ... products are direct use of a vacuum-type ... a result in minutes. VerifyNow IIb/IIIa, the ...
... ComboMap system provides both pressure and ... singly or in a combined screen ... SmartWire and Volcano's unique Doppler FloWire. ... valuable tools to assess ambiguous or ...
Medicine Products: